These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 369967)

  • 1. [Immunological problems in radiotherapy and adjuvant cytostatic chemotherapy of breast cancer].
    Pusztai-Markos Z
    Fortschr Med; 1979 Mar; 97(11):487-93. PubMed ID: 369967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adjuvant chemo- and radiotherapy on the cellular immune system of breast cancer patients.
    Mellios T; Ko HL; Beuth J
    In Vivo; 2010; 24(2):227-30. PubMed ID: 20364000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slope analysis of plasma carcinoembryonic antigen levels in monitoring response to treatment in patients with metastatic carcinoma of the breast.
    Koch M; Paterson AH; McPherson TA
    Clin Oncol; 1980 Dec; 6(4):323-7. PubMed ID: 7460406
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of chemotherapy in adjuvant treatment of breast cancer: modulation of the immune status].
    Fargeot P; Guerrin J
    Bull Cancer; 1984; 71(4):346-53. PubMed ID: 6388673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiotherapy and breast cancer. A review of the literature].
    Scarpati D; Corvo R; Franzone P; Sorice G
    Ann Ital Chir; 1991; 62(5):443-60. PubMed ID: 1801623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
    Villani C
    Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic and chemotherapeutic parameters in a model breast tumor system.
    Rugmann RA; Stolfi RL; Hayworth PE; Martin DS
    Cancer Chemother Rep 2; 1974 Mar; 4(1):25-32. PubMed ID: 4826497
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.
    Falkson HC; van der Watt JJ; Portugal MA; Schoeman HS; Falkson G
    Cancer Treat Rep; 1979 Aug; 63(8):1303-9. PubMed ID: 476707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune reactions in breast cancer patients (author's transl)].
    Sergejew SI; Gorodilowa WW; Baschenowa AP; Mandrik EW; Kasjanow IW
    Arch Geschwulstforsch; 1977; 47(5):421-7. PubMed ID: 412486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific immunotherapy in metastasizing breast cancer combined with chemotherapy. A prospective randomized study].
    Graninger W; Bettelheim P; Jakesz R; Rainer H; Moser K; Mörz R; Miksche M
    Acta Med Austriaca Suppl; 1979; 6():322-4. PubMed ID: 299220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modern view of adjuvant chemotherapy in carcinoma of the breast].
    Lorenz I
    Cas Lek Cesk; 1989 Apr; 128(15):449-52. PubMed ID: 2736585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subpopulations and reactivity in breast cancer recurrence following adjuvant postoperative chemotherapy.
    Petrini B; Rotstein S; Blomgren H; Wasserman J; Baral E
    Anticancer Res; 1984; 4(3):151-6. PubMed ID: 6465853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients. Influence of the treatment on the markers.
    Walach N; Guterman A; Zaidman JL; Scharf S; Weinberger L; Kaufman S
    Neoplasma; 1990; 37(6):627-30. PubMed ID: 2274082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological aspects of anticancer chemotherapy].
    Zitvogel L; Tesniere A; Apetoh L; Ghiringhelli F; Kroemer G
    Bull Acad Natl Med; 2008 Oct; 192(7):1469-87; discussion 1487-9. PubMed ID: 19445369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
    Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI
    Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.